Bioactivity:

GSK3532795 is an orally active inhibitor of HIV-1 maturation. GSK3532795 combines broad coverage of polymorphic viruses (EC50: 15 nM toward a panel of common polymorphisms representative of 96.5% HIV-1 subtype B virus) with a favorable pharmacokinetic pro

CAS nr:

2097784-79-5

Purity:

98%

Molecular Weight:

805,05

SMILES:

O=C(O)C1=CC=C(C2=CC[C@]3(C)[C@@]4([H])CC[C@]5([H])[C@@]6([H])[C@H](C(C)=C)CC[C@]6(NCCN7CCS(CC7)(=O)=O)CC[C@](C)5[C@@](C)4CC[C@]([H])3C2(C)C)C=C1.O=C(O)C(F)(F)F

Formula:

C44H63F3N2O6S

Pathway:

Target: